Founders Fund V Management, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Founders Fund V Management, LLC reported 4 stock positions worth $846 thousand. Its top holding was Cyclo Therapeutics (CYTH) at 72.2% of the portfolio, followed by Rigetti Computing (RGTI, 11.2%) and Notable Labs (NTBLQ, 8.8%). Compared with Q1 2024, it opened 1 new position and sold out of 1. The biggest buy was a new position in Notable Labs (NTBLQ) and the biggest sale an exit from Nova (NVMI).

Most Recent 13F
Q4 2025
Location
SAN FRANCISCO, CA
CIK
0001697733
Portfolio Value
$846K (Q2 2024)
SEC Filing
0001085146-24-003984 ↗ filed Aug 14, 2024

Holdings Value

0$1.0M$2.0M$3.0M Q1 2024: $1.1M Q1 2024 Q2 2024: $846K $846K Q2 2024 Q3 2024: $572K Q3 2024 Q4 2024: $1.7M Q4 2024 Q1 2025: $1.1M Q1 2025 Q2 2025: $1.4M Q2 2025 Q3 2025: $2.9M Q3 2025 Q4 2025: $2.2M Q4 2025

Holdings 4 stocks · $846K

CYTH Cyclo Therapeutics Inc. 72.16% 480,708 $610K No change
RGTI Rigetti Computing Inc. 11.21% 88,621 $95K No change
NTBLQ Notable Labs Ltd. 8.78% 117,924 $74K New
UNBX Unity Biotechnology Inc. 7.85% 49,172 $66K No change

Portfolio Sells Q1 2024 → Q2 2024

NVMI Nova Ltd. Sold out 0.00% −19.09

Portfolio Buys Q1 2024 → Q2 2024

NTBLQ Notable Labs Ltd. New 8.78% +8.78

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 2$2.2MRGTI, RFL
Q3 2025 2$2.9MRGTI, RFL
Q2 2025 4$1.4MRGTI, RFL, UNBX, PRCH
Q1 2025 3$1.1MRGTI, RFL, UNBX
Q4 2024 3$1.7MRGTI, CYTH, UNBX
Q3 2024Amended 4$572KCYTH, UNBX, RGTI, NTBLQ
Q2 2024 4$846KCYTH, RGTI, NTBLQ, UNBX
Q1 2024 4$1.1MCYTH, NVMI, RGTI, UNBX